Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.

Identifieur interne : 003102 ( PubMed/Curation ); précédent : 003101; suivant : 003103

Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.

Auteurs : Stephany N. Duda [États-Unis] ; Amanda M. Farr [États-Unis] ; Mary Lou Lindegren [États-Unis] ; Meridith Blevins [États-Unis] ; C William Wester [États-Unis] ; Kara Wools-Kaloustian [États-Unis] ; Didier K. Ekouevi [Togo] ; Matthias Egger [Suisse] ; Jennifer Hemingway-Foday [États-Unis] ; David A. Cooper [Australie] ; Richard D. Moore [États-Unis] ; Catherine C. Mcgowan [États-Unis] ; Denis Nash [États-Unis]

Source :

RBID : pubmed:25516092

Descripteurs français

English descriptors

Abstract

HIV care and treatment programmes worldwide are transforming as they push to deliver universal access to essential prevention, care and treatment services to persons living with HIV and their communities. The characteristics and capacity of these HIV programmes affect patient outcomes and quality of care. Despite the importance of ensuring optimal outcomes, few studies have addressed the capacity of HIV programmes to deliver comprehensive care. We sought to describe such capacity in HIV programmes in seven regions worldwide.

PubMed: 25516092

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:25516092

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.</title>
<author>
<name sortKey="Duda, Stephany N" sort="Duda, Stephany N" uniqKey="Duda S" first="Stephany N" last="Duda">Stephany N. Duda</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Informatics, Vanderbilt School of Medicine, Nashville, TN, USA; stephany.duda@vanderbilt.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Department of Biomedical Informatics, Vanderbilt School of Medicine, Nashville, TN</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Farr, Amanda M" sort="Farr, Amanda M" uniqKey="Farr A" first="Amanda M" last="Farr">Amanda M. Farr</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Life Sciences, Truven Health Analytics, Cambridge, MA, USA; School of Public Health, City University of New York, New York, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Life Sciences, Truven Health Analytics, Cambridge, MA, USA; School of Public Health, City University of New York, New York, NY</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Lindegren, Mary Lou" sort="Lindegren, Mary Lou" uniqKey="Lindegren M" first="Mary Lou" last="Lindegren">Mary Lou Lindegren</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, Vanderbilt School of Medicine, Nashville, TN, USA; Department of Health Policy, Vanderbilt School of Medicine, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, Vanderbilt School of Medicine, Nashville, TN, USA; Department of Health Policy, Vanderbilt School of Medicine, Nashville, TN</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Blevins, Meridith" sort="Blevins, Meridith" uniqKey="Blevins M" first="Meridith" last="Blevins">Meridith Blevins</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biostatistics, Vanderbilt School of Medicine, Nashville, TN, USA; Vanderbilt Institute for Global Health (VIGH), Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biostatistics, Vanderbilt School of Medicine, Nashville, TN, USA; Vanderbilt Institute for Global Health (VIGH), Nashville, TN</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wester, C William" sort="Wester, C William" uniqKey="Wester C" first="C William" last="Wester">C William Wester</name>
<affiliation wicri:level="1">
<nlm:affiliation>Vanderbilt Institute for Global Health (VIGH), Nashville, TN, USA; Department of Medicine, Division of Infectious Diseases, Vanderbilt School of Medicine, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Vanderbilt Institute for Global Health (VIGH), Nashville, TN, USA; Department of Medicine, Division of Infectious Diseases, Vanderbilt School of Medicine, Nashville, TN</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wools Kaloustian, Kara" sort="Wools Kaloustian, Kara" uniqKey="Wools Kaloustian K" first="Kara" last="Wools-Kaloustian">Kara Wools-Kaloustian</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Indiana University School of Medicine, Indianapolis, IN</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Ekouevi, Didier K" sort="Ekouevi, Didier K" uniqKey="Ekouevi D" first="Didier K" last="Ekouevi">Didier K. Ekouevi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Université de Bordeaux, ISPED, centre Inserm U897 Épidémiologie-Biostatistique, 33000, Bordeaux, France; Programme PAC-CI, Site ANRS de Côte d'Ivoire, Abidjan, Côte d'Ivoire; Université de Lomé, Faculté des Sciences de la Santé, Départment de Santé Publique, Lomé, Togo.</nlm:affiliation>
<country xml:lang="fr">Togo</country>
<wicri:regionArea>Université de Bordeaux, ISPED, centre Inserm U897 Épidémiologie-Biostatistique, 33000, Bordeaux, France; Programme PAC-CI, Site ANRS de Côte d'Ivoire, Abidjan, Côte d'Ivoire; Université de Lomé, Faculté des Sciences de la Santé, Départment de Santé Publique, Lomé</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Egger, Matthias" sort="Egger, Matthias" uniqKey="Egger M" first="Matthias" last="Egger">Matthias Egger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Hemingway Foday, Jennifer" sort="Hemingway Foday, Jennifer" uniqKey="Hemingway Foday J" first="Jennifer" last="Hemingway-Foday">Jennifer Hemingway-Foday</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Triangle Institute, Raleigh, NC, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Research Triangle Institute, Raleigh, NC</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Cooper, David A" sort="Cooper, David A" uniqKey="Cooper D" first="David A" last="Cooper">David A. Cooper</name>
<affiliation wicri:level="1">
<nlm:affiliation>Kirby Institute, University of New South Wales, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Kirby Institute, University of New South Wales, Sydney</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Moore, Richard D" sort="Moore, Richard D" uniqKey="Moore R" first="Richard D" last="Moore">Richard D. Moore</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health Baltimore, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health Baltimore, MD</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Mcgowan, Catherine C" sort="Mcgowan, Catherine C" uniqKey="Mcgowan C" first="Catherine C" last="Mcgowan">Catherine C. Mcgowan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, Division of Infectious Diseases, Vanderbilt School of Medicine, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Infectious Diseases, Vanderbilt School of Medicine, Nashville, TN</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Nash, Denis" sort="Nash, Denis" uniqKey="Nash D" first="Denis" last="Nash">Denis Nash</name>
<affiliation wicri:level="1">
<nlm:affiliation>Epidemiology and Biostatistics Program, Hunter College, City University of New York, New York, NY, USA; Doctor of Public Health Programs (CUNY SPH), School of Public Health, City University of New York, New York, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Epidemiology and Biostatistics Program, Hunter College, City University of New York, New York, NY, USA; Doctor of Public Health Programs (CUNY SPH), School of Public Health, City University of New York, New York, NY</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25516092</idno>
<idno type="pmid">25516092</idno>
<idno type="wicri:Area/PubMed/Corpus">003212</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003212</idno>
<idno type="wicri:Area/PubMed/Curation">003102</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003102</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.</title>
<author>
<name sortKey="Duda, Stephany N" sort="Duda, Stephany N" uniqKey="Duda S" first="Stephany N" last="Duda">Stephany N. Duda</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Informatics, Vanderbilt School of Medicine, Nashville, TN, USA; stephany.duda@vanderbilt.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Department of Biomedical Informatics, Vanderbilt School of Medicine, Nashville, TN</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Farr, Amanda M" sort="Farr, Amanda M" uniqKey="Farr A" first="Amanda M" last="Farr">Amanda M. Farr</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Life Sciences, Truven Health Analytics, Cambridge, MA, USA; School of Public Health, City University of New York, New York, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Life Sciences, Truven Health Analytics, Cambridge, MA, USA; School of Public Health, City University of New York, New York, NY</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Lindegren, Mary Lou" sort="Lindegren, Mary Lou" uniqKey="Lindegren M" first="Mary Lou" last="Lindegren">Mary Lou Lindegren</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, Vanderbilt School of Medicine, Nashville, TN, USA; Department of Health Policy, Vanderbilt School of Medicine, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, Vanderbilt School of Medicine, Nashville, TN, USA; Department of Health Policy, Vanderbilt School of Medicine, Nashville, TN</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Blevins, Meridith" sort="Blevins, Meridith" uniqKey="Blevins M" first="Meridith" last="Blevins">Meridith Blevins</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biostatistics, Vanderbilt School of Medicine, Nashville, TN, USA; Vanderbilt Institute for Global Health (VIGH), Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biostatistics, Vanderbilt School of Medicine, Nashville, TN, USA; Vanderbilt Institute for Global Health (VIGH), Nashville, TN</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wester, C William" sort="Wester, C William" uniqKey="Wester C" first="C William" last="Wester">C William Wester</name>
<affiliation wicri:level="1">
<nlm:affiliation>Vanderbilt Institute for Global Health (VIGH), Nashville, TN, USA; Department of Medicine, Division of Infectious Diseases, Vanderbilt School of Medicine, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Vanderbilt Institute for Global Health (VIGH), Nashville, TN, USA; Department of Medicine, Division of Infectious Diseases, Vanderbilt School of Medicine, Nashville, TN</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wools Kaloustian, Kara" sort="Wools Kaloustian, Kara" uniqKey="Wools Kaloustian K" first="Kara" last="Wools-Kaloustian">Kara Wools-Kaloustian</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Indiana University School of Medicine, Indianapolis, IN</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Ekouevi, Didier K" sort="Ekouevi, Didier K" uniqKey="Ekouevi D" first="Didier K" last="Ekouevi">Didier K. Ekouevi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Université de Bordeaux, ISPED, centre Inserm U897 Épidémiologie-Biostatistique, 33000, Bordeaux, France; Programme PAC-CI, Site ANRS de Côte d'Ivoire, Abidjan, Côte d'Ivoire; Université de Lomé, Faculté des Sciences de la Santé, Départment de Santé Publique, Lomé, Togo.</nlm:affiliation>
<country xml:lang="fr">Togo</country>
<wicri:regionArea>Université de Bordeaux, ISPED, centre Inserm U897 Épidémiologie-Biostatistique, 33000, Bordeaux, France; Programme PAC-CI, Site ANRS de Côte d'Ivoire, Abidjan, Côte d'Ivoire; Université de Lomé, Faculté des Sciences de la Santé, Départment de Santé Publique, Lomé</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Egger, Matthias" sort="Egger, Matthias" uniqKey="Egger M" first="Matthias" last="Egger">Matthias Egger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Hemingway Foday, Jennifer" sort="Hemingway Foday, Jennifer" uniqKey="Hemingway Foday J" first="Jennifer" last="Hemingway-Foday">Jennifer Hemingway-Foday</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Triangle Institute, Raleigh, NC, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Research Triangle Institute, Raleigh, NC</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Cooper, David A" sort="Cooper, David A" uniqKey="Cooper D" first="David A" last="Cooper">David A. Cooper</name>
<affiliation wicri:level="1">
<nlm:affiliation>Kirby Institute, University of New South Wales, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Kirby Institute, University of New South Wales, Sydney</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Moore, Richard D" sort="Moore, Richard D" uniqKey="Moore R" first="Richard D" last="Moore">Richard D. Moore</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health Baltimore, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health Baltimore, MD</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Mcgowan, Catherine C" sort="Mcgowan, Catherine C" uniqKey="Mcgowan C" first="Catherine C" last="Mcgowan">Catherine C. Mcgowan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, Division of Infectious Diseases, Vanderbilt School of Medicine, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Infectious Diseases, Vanderbilt School of Medicine, Nashville, TN</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Nash, Denis" sort="Nash, Denis" uniqKey="Nash D" first="Denis" last="Nash">Denis Nash</name>
<affiliation wicri:level="1">
<nlm:affiliation>Epidemiology and Biostatistics Program, Hunter College, City University of New York, New York, NY, USA; Doctor of Public Health Programs (CUNY SPH), School of Public Health, City University of New York, New York, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Epidemiology and Biostatistics Program, Hunter College, City University of New York, New York, NY, USA; Doctor of Public Health Programs (CUNY SPH), School of Public Health, City University of New York, New York, NY</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of the International AIDS Society</title>
<idno type="eISSN">1758-2652</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Africa South of the Sahara</term>
<term>Americas</term>
<term>Australasia</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Comprehensive Health Care</term>
<term>Female</term>
<term>HIV Infections (diagnosis)</term>
<term>HIV Infections (drug therapy)</term>
<term>HIV Infections (epidemiology)</term>
<term>HIV Infections (prevention & control)</term>
<term>Health Services Research</term>
<term>Humans</term>
<term>Male</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Afrique subsaharienne</term>
<term>Amériques</term>
<term>Australasie</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Infections à VIH ()</term>
<term>Infections à VIH (diagnostic)</term>
<term>Infections à VIH (traitement médicamenteux)</term>
<term>Infections à VIH (épidémiologie)</term>
<term>Mâle</term>
<term>Recherche sur les services de santé</term>
<term>Services de santé polyvalents</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Africa South of the Sahara</term>
<term>Americas</term>
<term>Australasia</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Comprehensive Health Care</term>
<term>Female</term>
<term>Health Services Research</term>
<term>Humans</term>
<term>Male</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Afrique subsaharienne</term>
<term>Amériques</term>
<term>Australasie</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Infections à VIH</term>
<term>Mâle</term>
<term>Recherche sur les services de santé</term>
<term>Services de santé polyvalents</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">HIV care and treatment programmes worldwide are transforming as they push to deliver universal access to essential prevention, care and treatment services to persons living with HIV and their communities. The characteristics and capacity of these HIV programmes affect patient outcomes and quality of care. Despite the importance of ensuring optimal outcomes, few studies have addressed the capacity of HIV programmes to deliver comprehensive care. We sought to describe such capacity in HIV programmes in seven regions worldwide.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">25516092</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>06</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>07</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1758-2652</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>17</Volume>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Journal of the International AIDS Society</Title>
<ISOAbbreviation>J Int AIDS Soc</ISOAbbreviation>
</Journal>
<ArticleTitle>Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.</ArticleTitle>
<Pagination>
<MedlinePgn>19045</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.7448/IAS.17.1.19045</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">HIV care and treatment programmes worldwide are transforming as they push to deliver universal access to essential prevention, care and treatment services to persons living with HIV and their communities. The characteristics and capacity of these HIV programmes affect patient outcomes and quality of care. Despite the importance of ensuring optimal outcomes, few studies have addressed the capacity of HIV programmes to deliver comprehensive care. We sought to describe such capacity in HIV programmes in seven regions worldwide.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Staff from 128 sites in 41 countries participating in the International epidemiologic Databases to Evaluate AIDS completed a site survey from 2009 to 2010, including sites in the Asia-Pacific region (n=20), Latin America and the Caribbean (n=7), North America (n=7), Central Africa (n=12), East Africa (n=51), Southern Africa (n=16) and West Africa (n=15). We computed a measure of the comprehensiveness of care based on seven World Health Organization-recommended essential HIV services.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Most sites reported serving urban (61%; region range (rr): 33-100%) and both adult and paediatric populations (77%; rr: 29-96%). Only 45% of HIV clinics that reported treating children had paediatricians on staff. As for the seven essential services, survey respondents reported that CD4+ cell count testing was available to all but one site, while tuberculosis (TB) screening and community outreach services were available in 80 and 72%, respectively. The remaining four essential services - nutritional support (82%), combination antiretroviral therapy adherence support (88%), prevention of mother-to-child transmission (PMTCT) (94%) and other prevention and clinical management services (97%) - were uniformly available. Approximately half (46%) of sites reported offering all seven services. Newer sites and sites in settings with low rankings on the UN Human Development Index (HDI), especially those in the President's Emergency Plan for AIDS Relief focus countries, tended to offer a more comprehensive array of essential services. HIV care programme characteristics and comprehensiveness varied according to the number of years the site had been in operation and the HDI of the site setting, with more recently established clinics in low-HDI settings reporting a more comprehensive array of available services. Survey respondents frequently identified contact tracing of patients, patient outreach, nutritional counselling, onsite viral load testing, universal TB screening and the provision of isoniazid preventive therapy as unavailable services.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study serves as a baseline for on-going monitoring of the evolution of care delivery over time and lays the groundwork for evaluating HIV treatment outcomes in relation to site capacity for comprehensive care.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Duda</LastName>
<ForeName>Stephany N</ForeName>
<Initials>SN</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Informatics, Vanderbilt School of Medicine, Nashville, TN, USA; stephany.duda@vanderbilt.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Farr</LastName>
<ForeName>Amanda M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Department of Life Sciences, Truven Health Analytics, Cambridge, MA, USA; School of Public Health, City University of New York, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lindegren</LastName>
<ForeName>Mary Lou</ForeName>
<Initials>ML</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Vanderbilt School of Medicine, Nashville, TN, USA; Department of Health Policy, Vanderbilt School of Medicine, Nashville, TN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blevins</LastName>
<ForeName>Meridith</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Biostatistics, Vanderbilt School of Medicine, Nashville, TN, USA; Vanderbilt Institute for Global Health (VIGH), Nashville, TN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wester</LastName>
<ForeName>C William</ForeName>
<Initials>CW</Initials>
<AffiliationInfo>
<Affiliation>Vanderbilt Institute for Global Health (VIGH), Nashville, TN, USA; Department of Medicine, Division of Infectious Diseases, Vanderbilt School of Medicine, Nashville, TN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wools-Kaloustian</LastName>
<ForeName>Kara</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ekouevi</LastName>
<ForeName>Didier K</ForeName>
<Initials>DK</Initials>
<AffiliationInfo>
<Affiliation>Université de Bordeaux, ISPED, centre Inserm U897 Épidémiologie-Biostatistique, 33000, Bordeaux, France; Programme PAC-CI, Site ANRS de Côte d'Ivoire, Abidjan, Côte d'Ivoire; Université de Lomé, Faculté des Sciences de la Santé, Départment de Santé Publique, Lomé, Togo.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Egger</LastName>
<ForeName>Matthias</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hemingway-Foday</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Research Triangle Institute, Raleigh, NC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cooper</LastName>
<ForeName>David A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>Kirby Institute, University of New South Wales, Sydney, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moore</LastName>
<ForeName>Richard D</ForeName>
<Initials>RD</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health Baltimore, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McGowan</LastName>
<ForeName>Catherine C</ForeName>
<Initials>CC</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Infectious Diseases, Vanderbilt School of Medicine, Nashville, TN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nash</LastName>
<ForeName>Denis</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Epidemiology and Biostatistics Program, Hunter College, City University of New York, New York, NY, USA; Doctor of Public Health Programs (CUNY SPH), School of Public Health, City University of New York, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>International Epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AA016893</GrantID>
<Acronym>AA</Acronym>
<Agency>NIAAA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 AI027767</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-AA16893</GrantID>
<Acronym>AA</Acronym>
<Agency>NIAAA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 TR000445</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R24-AI067039</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01AI069924</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 AI094189</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 AI054999</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K24 DA000432</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AI096186</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 DA036935</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 MH043520</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AI069923</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30-AI036219</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30-AI094189</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R24 AI067039</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01AI069907</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01AI069911</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30-AI50410</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01AI069918</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>N02CP55504</GrantID>
<Acronym>CP</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01A096299</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AI069911</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K24-DA00432</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01AI069919</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30-AI27757</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K24-AI065298</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AI069919</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01A1096186</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AI069918</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1-TR000083</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K24 AI065298</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AI069907</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 TR000083</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 AI027757</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>KL2 TR000421</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01AI069923</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30-AI27767</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-DA11602</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01-DA036935</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 AI036219</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AI069924</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 AI050410</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30-AI54999</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>12</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>J Int AIDS Soc</MedlineTA>
<NlmUniqueID>101478566</NlmUniqueID>
<ISSNLinking>1758-2652</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CitationSubset>X</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 2006 Aug 9;296(6):679-90</RefSource>
<PMID Version="1">16896111</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMJ. 2002 Oct 26;325(7370):954-7</RefSource>
<PMID Version="1">12399350</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Epidemiol. 2007 Oct;36(5):969-76</RefSource>
<PMID Version="1">17846055</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trop Med Int Health. 2008 Jul;13(7):870-9</RefSource>
<PMID Version="1">18373510</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bull World Health Organ. 2008 Jul;86(7):559-67</RefSource>
<PMID Version="1">18670668</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 2008 Nov 12;22(17):2291-302</RefSource>
<PMID Version="1">18981768</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biomed Inform. 2009 Apr;42(2):377-81</RefSource>
<PMID Version="1">18929686</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Med. 2009 Apr 28;6(4):e1000066</RefSource>
<PMID Version="1">19399157</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2009;4(6):e5790</RefSource>
<PMID Version="1">19495419</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):49-55</RefSource>
<PMID Version="1">19617847</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 2009 Nov;52 Suppl 1:S58-62</RefSource>
<PMID Version="1">19858942</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS Care. 2010 Jun;22(6):775-83</RefSource>
<PMID Version="1">20473792</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trop Med Int Health. 2010 Jun;15 Suppl 1:1-15</RefSource>
<PMID Version="1">20586956</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr HIV/AIDS Rep. 2010 Nov;7(4):234-44</RefSource>
<PMID Version="1">20820972</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1:S27-31</RefSource>
<PMID Version="1">21045596</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):199-203</RefSource>
<PMID Version="1">21239991</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 2011 Jul 31;25(12):1547-8</RefSource>
<PMID Version="1">21747236</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 2011 Jul 31;25(12):1523-33</RefSource>
<PMID Version="1">21750418</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 2011 May 1;57(1):e1-6</RefSource>
<PMID Version="1">21346585</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Med. 2011 Jul;8(7):e1001056</RefSource>
<PMID Version="1">21811403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Public Health Nutr. 2012 May;15(5):938-47</RefSource>
<PMID Version="1">21806867</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(5):e37125</RefSource>
<PMID Version="1">22615917</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(6):e38443</RefSource>
<PMID Version="1">22685569</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):216-20</RefSource>
<PMID Version="1">22732465</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Epidemiol. 2012 Oct;41(5):1256-64</RefSource>
<PMID Version="1">21593078</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Int AIDS Soc. 2012;15(2):17422</RefSource>
<PMID Version="1">23199800</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):e7-e13</RefSource>
<PMID Version="1">22955053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(1):e53586</RefSource>
<PMID Version="1">23326462</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Int AIDS Soc. 2013;16:17998</RefSource>
<PMID Version="1">23336728</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Health Care Poor Underserved. 2013 Feb;24(1):359-83</RefSource>
<PMID Version="1">23377739</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2006 Mar 11;367(9513):817-24</RefSource>
<PMID Version="1">16530575</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Epidemiol. 2005 Oct;34(5):979-86</RefSource>
<PMID Version="1">16157617</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Epidemiol. 2007 Apr;36(2):294-301</RefSource>
<PMID Version="1">17213214</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017954" MajorTopicYN="N" Type="Geographic">Africa South of the Sahara</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000569" MajorTopicYN="N" Type="Geographic">Americas</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D044362" MajorTopicYN="N" Type="Geographic">Australasia</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003191" MajorTopicYN="Y">Comprehensive Health Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006302" MajorTopicYN="Y">Health Services Research</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4268491</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">HIV care capacity</Keyword>
<Keyword MajorTopicYN="N">HIV/AIDS</Keyword>
<Keyword MajorTopicYN="N">clinic characteristics</Keyword>
<Keyword MajorTopicYN="N">comprehensive care</Keyword>
<Keyword MajorTopicYN="N">resource-limited settings</Keyword>
</KeywordList>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Saphonn</LastName>
<ForeName>Vonthanak</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Saramony</LastName>
<ForeName>Sarun</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Han</LastName>
<ForeName>Ning</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Man Po</ForeName>
<Initials>MP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Fujie</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bele</LastName>
<ForeName>Vivek</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pujari</LastName>
<ForeName>Sanjay</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Merati</LastName>
<ForeName>Tuti</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ramadian</LastName>
<ForeName>Okki</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yuliana</LastName>
<ForeName>Flora</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yunihastuti</LastName>
<ForeName>Evy</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Oka</LastName>
<ForeName>Shinichi</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Takano</LastName>
<ForeName>Misao</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kajindran</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kamarulzaman</LastName>
<ForeName>Adeeba</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Low</LastName>
<ForeName>Lee Lee</ForeName>
<Initials>LL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sim</LastName>
<ForeName>Benedict L H</ForeName>
<Initials>BL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Capistrano</LastName>
<ForeName>Rowena</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ditangco</LastName>
<ForeName>Rossana</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kuo</LastName>
<ForeName>Lou Hui</ForeName>
<Initials>LH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wong</LastName>
<ForeName>Wing Wai</ForeName>
<Initials>WW</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chaiwarith</LastName>
<ForeName>Romanee</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Khongpattanayothin</LastName>
<ForeName>Mana</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kiertiburanakul</LastName>
<ForeName>Sasisopin</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kotarathititum</LastName>
<ForeName>Wilai</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Phanuphak</LastName>
<ForeName>Praphan</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Piyavong</LastName>
<ForeName>Bucha</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fou</LastName>
<ForeName>Estelle</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ng</LastName>
<ForeName>Oon Tek</ForeName>
<Initials>OT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Choi</LastName>
<ForeName>Jun Yong</ForeName>
<Initials>JY</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Han</LastName>
<ForeName>Sang Hoon</ForeName>
<Initials>SH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carr</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chuah</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dickson</LastName>
<ForeName>Bridget</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hoy</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ji</LastName>
<ForeName>Jing</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Norris</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Templeton</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Watson</LastName>
<ForeName>Kerrie</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bendall</LastName>
<ForeName>Courtney</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cooper</LastName>
<ForeName>David A</ForeName>
<Initials>DA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jiamsakul</LastName>
<ForeName>Awachana</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Law</LastName>
<ForeName>Matthew G</ForeName>
<Initials>MG</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McManus</LastName>
<ForeName>Hamish</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Durier</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Petersen</LastName>
<ForeName>Boondarika</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sohn</LastName>
<ForeName>Annette H</ForeName>
<Initials>AH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rodriguez</LastName>
<ForeName>Benigno</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Moore</LastName>
<ForeName>Richard D</ForeName>
<Initials>RD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gill</LastName>
<ForeName>M John</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Saag</LastName>
<ForeName>Michael S</ForeName>
<Initials>MS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mugavero</LastName>
<ForeName>Michael J</ForeName>
<Initials>MJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Willig</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eron</LastName>
<ForeName>Joseph J</ForeName>
<Initials>JJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Napravnik</LastName>
<ForeName>Sonia</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kitahata</LastName>
<ForeName>Mari M</ForeName>
<Initials>MM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Crane</LastName>
<ForeName>Heidi M</ForeName>
<Initials>HM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Drozd</LastName>
<ForeName>Daniel R</ForeName>
<Initials>DR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sterling</LastName>
<ForeName>Timothy R</ForeName>
<Initials>TR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Haas</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bebawy</LastName>
<ForeName>Sally</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Turner</LastName>
<ForeName>Megan</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Moore</LastName>
<ForeName>Richard D</ForeName>
<Initials>RD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Saag</LastName>
<ForeName>Michael S</ForeName>
<Initials>MS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gange</LastName>
<ForeName>Stephen J</ForeName>
<Initials>SJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kitahata</LastName>
<ForeName>Mari M</ForeName>
<Initials>MM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Althoff</LastName>
<ForeName>Keri N</ForeName>
<Initials>KN</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McKaig</LastName>
<ForeName>Rosemary G</ForeName>
<Initials>RG</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Justice</LastName>
<ForeName>Amy C</ForeName>
<Initials>AC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Freeman</LastName>
<ForeName>Aimee M</ForeName>
<Initials>AM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Moore</LastName>
<ForeName>Richard D</ForeName>
<Initials>RD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Freeman</LastName>
<ForeName>Aimee M</ForeName>
<Initials>AM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lent</LastName>
<ForeName>Carol</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kitahata</LastName>
<ForeName>Mari M</ForeName>
<Initials>MM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Van Rompaey</LastName>
<ForeName>Stephen E</ForeName>
<Initials>SE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Crane</LastName>
<ForeName>Heidi M</ForeName>
<Initials>HM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Drozd</LastName>
<ForeName>Daniel R</ForeName>
<Initials>DR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Morton</LastName>
<ForeName>Liz</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McReynolds</LastName>
<ForeName>Justin</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lober</LastName>
<ForeName>William B</ForeName>
<Initials>WB</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gange</LastName>
<ForeName>Stephen J</ForeName>
<Initials>SJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Althoff</LastName>
<ForeName>Keri N</ForeName>
<Initials>KN</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Abraham</LastName>
<ForeName>Alison G</ForeName>
<Initials>AG</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lau</LastName>
<ForeName>Bryan</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Jinbing</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jing</LastName>
<ForeName>Yuezhou</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Golub</LastName>
<ForeName>Elizabeth</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Modur</LastName>
<ForeName>Shari</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wong</LastName>
<ForeName>Cherise</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mendes</LastName>
<ForeName>Adell</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Masys</LastName>
<ForeName>Daniel R</ForeName>
<Initials>DR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Minor</LastName>
<ForeName>Brenda</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wehbe</LastName>
<ForeName>Firas</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cahn</LastName>
<ForeName>Pedro</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Krolewiecki</LastName>
<ForeName>Alejandro</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cesar</LastName>
<ForeName>Carina</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Schechter</LastName>
<ForeName>Mauro</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Faulhaber</LastName>
<ForeName>Jose Claudio</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wolff</LastName>
<ForeName>Marcelo</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cortes</LastName>
<ForeName>Claudia</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pape</LastName>
<ForeName>Jean W</ForeName>
<Initials>JW</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marcelin</LastName>
<ForeName>Adias</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Padgett</LastName>
<ForeName>Denis</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sierra-Madero</LastName>
<ForeName>Juan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vega</LastName>
<ForeName>Yanink Caro</ForeName>
<Initials>YC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gotuzzo</LastName>
<ForeName>Eduardo</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Akam</LastName>
<ForeName>Wilfred</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Urayeneza</LastName>
<ForeName>Esperance</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Uwingabiye</LastName>
<ForeName>Rose</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Modeste</LastName>
<ForeName>Kumbu</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Patou</LastName>
<ForeName>Wibina</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Coucou</LastName>
<ForeName>Ebondo</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kassamina</LastName>
<ForeName>Kumbu</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mpukela</LastName>
<ForeName>Marie-Agnès</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mafutaming</LastName>
<ForeName>Kambale</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Munyungu</LastName>
<ForeName>Nadine</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kabwe</LastName>
<ForeName>Jean</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mbaya</LastName>
<ForeName>Marcel</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lufindusu</LastName>
<ForeName>Sylvie</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Balimba</LastName>
<ForeName>Ashu</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Susan</LastName>
<ForeName>Bokeng</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Molu</LastName>
<ForeName>Brigitte Mfangam</ForeName>
<Initials>BM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Blessing</LastName>
<ForeName>Bongason</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Niyongabo</LastName>
<ForeName>Théodore</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nindagiye</LastName>
<ForeName>Emmanuel</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dusengamungu</LastName>
<ForeName>Cyrille</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Manariyo</LastName>
<ForeName>Marcel</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ayaya</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Diero</LastName>
<ForeName>Lameck</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yiannoutsos</LastName>
<ForeName>Constantin</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Musick</LastName>
<ForeName>Beverly S</ForeName>
<Initials>BS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lyamuya</LastName>
<ForeName>Rita</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mbaula</LastName>
<ForeName>Mayanga Francis</ForeName>
<Initials>MF</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mtiro</LastName>
<ForeName>Hussein</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wilfest</LastName>
<ForeName>Wilialfa</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mhinga</LastName>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Maruchu</LastName>
<ForeName>Isaria A</ForeName>
<Initials>IA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ssali</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ssemakadde</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Deo</LastName>
<ForeName>Wabwire</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mubiru</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Masaba</LastName>
<ForeName>J P M</ForeName>
<Initials>JP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Musaazi</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bwana</LastName>
<ForeName>Mwebesa</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Musinguzi</LastName>
<ForeName>Nicholas</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mbidde</LastName>
<ForeName>Mary</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kalanzi</LastName>
<ForeName>Harriet</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kambugu</LastName>
<ForeName>Andrew D</ForeName>
<Initials>AD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Orama</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mboya</LastName>
<ForeName>Emma</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Braitstein</LastName>
<ForeName>Paula</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sang</LastName>
<ForeName>Edwin</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chebet</LastName>
<ForeName>Janet</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chelobei</LastName>
<ForeName>Francis</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Josphat</LastName>
<ForeName>Maiyo</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ariya</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Namaemba</LastName>
<ForeName>Jentrix</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Munyisi</LastName>
<ForeName>Consolata</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ototo</LastName>
<ForeName>Rachel</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Caroline</LastName>
<ForeName>Kaibei</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Busaka</LastName>
<ForeName>Oscar</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bett</LastName>
<ForeName>Lynn Mildred</ForeName>
<Initials>LM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Simatwa</LastName>
<ForeName>Lilian</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hosea</LastName>
<ForeName>Some</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nancy</LastName>
<ForeName>Wamboi</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boit</LastName>
<ForeName>Lilian</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Biyegon</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Peter</LastName>
<ForeName>Chege</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Paron</LastName>
<ForeName>Moses</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nandi</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wycliffe</LastName>
<ForeName>Kivairo Ngadi</ForeName>
<Initials>KN</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Otieno</LastName>
<ForeName>Juliana</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Omolo</LastName>
<ForeName>Kennedy</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mukhwana</LastName>
<ForeName>Walter</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Koech</LastName>
<ForeName>Julius</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ndiege</LastName>
<ForeName>David Oyuko</ForeName>
<Initials>DO</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Owiti</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wasing'a</LastName>
<ForeName>Edwin</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Owengah</LastName>
<ForeName>Evelyne</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Juma</LastName>
<ForeName>Erick N</ForeName>
<Initials>EN</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kulzer</LastName>
<ForeName>Jayne</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Odhiambo</LastName>
<ForeName>Bernard</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tanser</LastName>
<ForeName>Frank</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hoffmann</LastName>
<ForeName>Christopher</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chi</LastName>
<ForeName>Benjamin</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Naniche</LastName>
<ForeName>Denise</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wood</LastName>
<ForeName>Robin</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Stinson</LastName>
<ForeName>Kathryn</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fatti</LastName>
<ForeName>Geoffrey</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Phiri</LastName>
<ForeName>Sam</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Giddy</LastName>
<ForeName>Janet</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chimbetete</LastName>
<ForeName>Cleophas</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Malisita</LastName>
<ForeName>Kennedy</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eley</LastName>
<ForeName>Brian</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hobbins</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kamenova</LastName>
<ForeName>Kamelia</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Faturiyele</LastName>
<ForeName>Olatunbosun</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fox</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Prozesky</LastName>
<ForeName>Hans</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Technau</LastName>
<ForeName>Karl</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sawry</LastName>
<ForeName>Shobna</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Egger</LastName>
<ForeName>Matthias</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bohlius</LastName>
<ForeName>Julia</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Blaser</LastName>
<ForeName>Nello</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Estill</LastName>
<ForeName>Janne</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Keiser</LastName>
<ForeName>Olivia</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wandeler</LastName>
<ForeName>Gilles</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Salazar-Vizcaya</LastName>
<ForeName>Luisa</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Haas</LastName>
<ForeName>Andreas</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ballif</LastName>
<ForeName>Marie</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rohner</LastName>
<ForeName>Eliane</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wyss</LastName>
<ForeName>Natascha</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Baranczuk</LastName>
<ForeName>Zofia</ForeName>
<Initials>Z</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Goodwin</LastName>
<ForeName>Kelly</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ostinelli</LastName>
<ForeName>Cam Ha Dao</ForeName>
<Initials>CH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Davies</LastName>
<ForeName>Mary-Ann</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boulle</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Campbell</LastName>
<ForeName>Lucy</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cornell</LastName>
<ForeName>Morna</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Johnson</LastName>
<ForeName>Leigh</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Maxwell</LastName>
<ForeName>Nicola</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Myer</LastName>
<ForeName>Landon</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Schomaker</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Porter</LastName>
<ForeName>Mireille</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eley</LastName>
<ForeName>Brian</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dabis</LastName>
<ForeName>François</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bissagnene</LastName>
<ForeName>Emmanuel</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Arrivé</LastName>
<ForeName>Elise</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Coffie</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ekouevi</LastName>
<ForeName>Didier</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jaquet</LastName>
<ForeName>Antoine</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Leroy</LastName>
<ForeName>Valériane</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lewden</LastName>
<ForeName>Charlotte</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>de Rekeneire</LastName>
<ForeName>Nathalie</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sasco</LastName>
<ForeName>Annie J</ForeName>
<Initials>AJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zannou</LastName>
<ForeName>Djimon Marcel</ForeName>
<Initials>DM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ahouada</LastName>
<ForeName>Carin</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Akakpo</LastName>
<ForeName>Jocelyn</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ahomadegbé</LastName>
<ForeName>Christelle</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bashi</LastName>
<ForeName>Jules</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gougounon-Houéto</LastName>
<ForeName>Alice</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Azon-Kouanou</LastName>
<ForeName>Angèle</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Houngbé</LastName>
<ForeName>Fabien</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sehonou</LastName>
<ForeName>Jean</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Drabo</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bognounou</LastName>
<ForeName>René</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dienderé</LastName>
<ForeName>Arnaud</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Traore</LastName>
<ForeName>Eliezer</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zoungrana</LastName>
<ForeName>Lassane</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zerbo</LastName>
<ForeName>Béatrice</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sawadogo</LastName>
<ForeName>Adrien Bruno</ForeName>
<Initials>AB</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zoungrana</LastName>
<ForeName>Jacques</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Héma</LastName>
<ForeName>Arsène</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Soré</LastName>
<ForeName>Ibrahim</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bado</LastName>
<ForeName>Guillaume</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tapsoba</LastName>
<ForeName>Achille</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Messou</LastName>
<ForeName>Eugène</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gnokoro</LastName>
<ForeName>Joachim Charles</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Koné</LastName>
<ForeName>Mamadou</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kouakou</LastName>
<ForeName>Guillaume Martial</ForeName>
<Initials>GM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bosse</LastName>
<ForeName>Clarisse Amani</ForeName>
<Initials>CA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brou</LastName>
<ForeName>Kouakou</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Assi</LastName>
<ForeName>Achi Isidore</ForeName>
<Initials>AI</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chenal</LastName>
<ForeName>Henri</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hawerlander</LastName>
<ForeName>Denise</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Soppi</LastName>
<ForeName>Franck</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Minga</LastName>
<ForeName>Albert</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Abo</LastName>
<ForeName>Yao</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yoboue</LastName>
<ForeName>Jean-Michel</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eholié</LastName>
<ForeName>Serge Paul</ForeName>
<Initials>SP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Amego</LastName>
<ForeName>Mensah Deborah Noelly</ForeName>
<Initials>MD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Andavi</LastName>
<ForeName>Viviane</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Diallo</LastName>
<ForeName>Zelica</ForeName>
<Initials>Z</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ello</LastName>
<ForeName>Frédéric</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tanon</LastName>
<ForeName>Aristophane Koffi</ForeName>
<Initials>AK</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Koule</LastName>
<ForeName>Serge Olivier</ForeName>
<Initials>SO</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Anzan</LastName>
<ForeName>Koffi Charles</ForeName>
<Initials>KC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Guehi</LastName>
<ForeName>Calixte</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wejse</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Da Silva</LastName>
<ForeName>Zacarias José</ForeName>
<Initials>ZJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Paulo</LastName>
<ForeName>Joao</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rodrigues</LastName>
<ForeName>Amabelia</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>da Silva</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Medina</LastName>
<ForeName>Candida</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Oliviera-Souto</LastName>
<ForeName>Ines</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Østergaard</LastName>
<ForeName>Lars</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Laursen</LastName>
<ForeName>Alex</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sodemann</LastName>
<ForeName>Morten</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Aaby</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fomsgaard</LastName>
<ForeName>Anders</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Erikstrup</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eugen-Olsen</LastName>
<ForeName>Jesper</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Leuenberger</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hebelamou</LastName>
<ForeName>Jean</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Maïga</LastName>
<ForeName>Moussa Y</ForeName>
<Initials>MY</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Diakité</LastName>
<ForeName>Fatoumata Fofana</ForeName>
<Initials>FF</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kalle</LastName>
<ForeName>Abdoulaye</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Katile</LastName>
<ForeName>Drissa</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Traore</LastName>
<ForeName>Hamar Alassane</ForeName>
<Initials>HA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Minta</LastName>
<ForeName>Daouda</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cissé</LastName>
<ForeName>Tidiani</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dembelé</LastName>
<ForeName>Mamadou</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Doumbia</LastName>
<ForeName>Mohammed</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fomba</LastName>
<ForeName>Mahamadou</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kaya</LastName>
<ForeName>Assétou Soukho</ForeName>
<Initials>AS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Traoré</LastName>
<ForeName>Abdoulaye M</ForeName>
<Initials>AM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Traoré</LastName>
<ForeName>Hamady</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Toure</LastName>
<ForeName>Amadou Abathina</ForeName>
<Initials>AA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Charurat</LastName>
<ForeName>Man</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kwaghe</LastName>
<ForeName>Vivian</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ajayi</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Alim</LastName>
<ForeName>Georgina</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dapiap</LastName>
<ForeName>Stephen</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Otu</LastName>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Igbinoba</LastName>
<ForeName>Festus</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Benson</LastName>
<ForeName>Okwara</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Adebamowo</LastName>
<ForeName>Clément</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>James</LastName>
<ForeName>Jesse</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Obaseki</LastName>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Osakede</LastName>
<ForeName>Philip</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Olasode</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Seydi</LastName>
<ForeName>Moussa</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sow</LastName>
<ForeName>Papa Salif</ForeName>
<Initials>PS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Diop</LastName>
<ForeName>Bernard</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Manga</LastName>
<ForeName>Noël Magloire</ForeName>
<Initials>NM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tine</LastName>
<ForeName>Judicael Malick</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bassabi</LastName>
<ForeName>Coumba Cissé</ForeName>
<Initials>CC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Patassi</LastName>
<ForeName>Akessiwe</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kotosso</LastName>
<ForeName>Awérou</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kariyare</LastName>
<ForeName>Benjamin Goilibe</ForeName>
<Initials>BG</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gbadamassi</LastName>
<ForeName>Gafarou</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Komi</LastName>
<ForeName>Agbo</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mensah-Zukong</LastName>
<ForeName>Kankoé Edem</ForeName>
<Initials>KE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pakpame</LastName>
<ForeName>Pinuwe</ForeName>
<Initials>P</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2014</Year>
<Month>02</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2014</Year>
<Month>07</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2014</Year>
<Month>08</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>12</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>12</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>6</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">25516092</ArticleId>
<ArticleId IdType="pii">19045</ArticleId>
<ArticleId IdType="pmc">PMC4268491</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003102 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003102 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:25516092
   |texte=   Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:25516092" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024